Effectiveness of Topiramate in Medically Complicated Patients with Status Epilepticus or Acute Refractory Seizures
Woojun Kim, Se Yoon Kwon, A Hyun Cho, Sung Chul Lim, Yeong In Kim, Young-Min Shon
J Epilepsy Res. 2011;1(2):52-56. Published online 2011 Dec 30 DOI: https://doi.org/10.14581/jer.11010
Citations to this article as recorded by 
Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review
Laurent M. Willems, Sebastian Bauer, Kolja Jahnke, Martin Voss, Felix Rosenow, Adam Strzelczyk
CNS Drugs.2020; 34(8): 801. CrossRef
Antiseizure medications in critical care: an update
Baxter Allen, Paul M. Vespa
Current Opinion in Critical Care.2019; 25(2): 117. CrossRef
Treatment of refractory and superrefractory status epilepticus with topiramate: A cohort study of 106 patients and a review of the literature
Anne Fechner, Kristina Hubert, Kolja Jahnke, Susanne Knake, Jürgen Konczalla, Katja Menzler, Michael W. Ronellenfitsch, Felix Rosenow, Adam Strzelczyk
Epilepsia.2019; 60(12): 2448. CrossRef
Topiramate in the Treatment of Generalized Convulsive Status Epilepticus in Adults: A Systematic Review with Individual Patient Data Analysis
Francesco Brigo, Nicola Luigi Bragazzi, Stanley C. Igwe, Raffaele Nardone, Eugen Trinka
Drugs.2017; 77(1): 67. CrossRef
Risk factors associated with the development of seizures among adult patients treated with ertapenem: A matched case-control study
Yi-Chien Lee, Yun-Jhong Huang, Miao-Chiu Hung, Sheng-Che Hung, Chih-Yen Hsiao, Hui-Ling Cho, Li-Fen Lai, Show-Hwa Tong, Jann-Tay Wang, Gilles van Luijtelaar
PLOS ONE.2017; 12(7): e0182046. CrossRef